Europe Solidaire Sans Frontières
Researchers still don’t know how well BA.2.86 will evade immunity or whether it will cause more severe disease than its predecessors.
The latest variant, or sublineage, of SARS-CoV-2 to emerge on the scene, BA.2.86, has public health experts on alert as COVID-19 hospitalizations begin to (...)
Over the last fifty years, few public health professionals have considered Marxism relevant, and few Marxists have treated pandemics as an imminent concern. We offer this paper to help both public health professionals and socialists view pandemics through a Marxist lens. Although our theory is (...)
Royal Society review looks at non-pharmaceutical interventions when applied in packages of several measures
Experts looked at the effectiveness of non-pharmaceutical interventions (NPIs) – not drugs or vaccines – when applied in packages that combine a number of measures that complement one (...)
Getting scientists to develop a medicine is a relatively small part of the solution to a pandemic. The more difficult thing is to get the medicine to the people who need it
If you were a South African health journalist during the late 1990s and early 2000s, you were mostly an Aids reporter. (...)
Governments worldwide are abandoning people to a debilitating disease with one simple trick: saying it no longer exists.
In this article written for Truthout, Tithi Bhattacharya raises, from personal experience, questions about the present and future impact of the Covid pandemic and current (...)
A report from the Be like Nina trade union
In 1990, there were 670,000 nurses in Ukraine. In 2017, there were almost half that number (360,000). In 2018, the healthcare reform started and the total number of personnel changed. However, if we compare the general data available from the (...)
There are effective vaccines for COVID-19 and effective treatments for HIV/AIDS, but both remain global epidemics. Medical researcher Sam Friedman explains how the profit system offers life-saving medicines to some of us while keeping them out of reach for others.
Capitalism is a system that (...)
There are a range of reasons people with long COVID may have poorer mental health.
Many people have persistent symptoms after recovering from COVID, a condition termed “long COVID”. The UK’s Office for National Statistics estimates 1.8 million people in the UK have long COVID symptoms at (...)
A recent study found 59% of people with long COVID had damage to at least one organ a year after their initial symptoms.
The latest data from the Office for National Statistics suggests that more than 1.2 million people in the UK report living with long COVID for 12 months or more.
Several (...)
As rich people plough money into ventilation to protect themselves, those with long Covid are treated as an embarrassment.
You could see Covid-19 as an empathy test. Who was prepared to suffer disruption and inconvenience for the sake of others, and who was not? The answer was often (...)
The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.
By almost any measure, the vaccination campaign against SARS-CoV-2, the virus that causes COVID-19, has been a global success.
As of (...)
Nearly all the wastewater samples from aircraft arriving in the UK showed evidence of COVID-infected passengers on board.
Small traces of many pathogens, such as viruses we may be infected with, are excreted when we go to the toilet. Ultimately, these agents find their way to municipal (...)
The debate over the risks of reinfections – which are likely to continue – could determine what precautions people take, but experts disagree on the data.
A recent study states that Covid-19 reinfections could pose additional risks to people’s long-term health – as compared to only getting (...)
After a year of omicron variants, will we ever see a new variant of concern?
The omicron variant of SARS-CoV-2, the virus that causes COVID-19, has now been around for more than a year. Before omicron became dominant, there had been a quick succession of named variants of concern – from (...)
While there are still far more questions than answers about long COVID-19, researchers are beginning to get a clearer picture of the health and economic consequences of the condition.
The Research Brief is a short take about interesting academic work.
The big idea
Even mild COVID-19 (...)
Masks are an easy and low-cost way to reduce the amount of virus entering the air and spreading to others.
The cold and flu season of 2022 has begun with a vengeance. Viruses that have been unusually scarce over the past three years are reappearing at remarkably high levels, sparking a (...)
There have been enough COVID infections in the UK since March 2020 for every person to have been infected between 1.3 and two times, according to mathematical modelling.
Of course, some people will have had COVID more than twice, and some won’t have had it at all. But COVID is not a “one and (...)
Almost three years into the pandemic, myths and misinformation remain widespread. Here we, a virologist and a public health researcher, debunk some common misconceptions about COVID.
--------------------
Myth 1: The virus is becoming milder
There’s a prevailing myth in the omicron era (...)
Nov 10 (Reuters) - The risk of death, hospitalization and serious health issues from COVID-19 jumps significantly with reinfection compared with a first bout with the virus, regardless of vaccination status, a study published on Thursday suggests.
“Reinfection with COVID-19 increases the (...)
Two new omicron subvariants, BQ.1 and BQ.1.1 could lead to another COVID surge. Here’s what we know so far.
Two new omicron subvariants, BQ.1 and BQ.1.1, are quickly gaining traction in the US, collectively accounting for 27% of infections as of October 29. Both are descendants of BA.5, the (...)
Twitter
Facebook